Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Short-chain fatty acid-producing gut bacteria are a heterogeneous group within the gut microbiota capable of fermenting undigested dietary carbohydrates into SCFAs such as acetate, propionate, and butyrate. Prominent SCFA producers include members of Firmicutes (e.g., Faecalibacterium, Roseburia, Ruminococcus, Lachnospiraceae), Bacteroidetes (e.g., Bacteroides, Parabacteroides), and some Actinobacteria and Verrucomicrobia (e.g., Akkermansia). SCFA production is essential for gut homeostasis, nourishes colonocytes, modulates immune responses, and protects against inflammation and metabolic disease. Deficiencies in these bacteria or their metabolites have been implicated in the pathogenesis of several disorders, including IBD, colorectal cancer, and metabolic syndrome. Therapeutic strategies to modulate these bacteria include dietary intervention (prebiotics), targeted probiotic formulations, and synbiotics.
Prebiotics: Increase growth/activity of SCFA producers by providing fermentable substrates Probiotics: Direct supplementation with bacteria capable of SCFA production Synbiotics: Combined enhancement via direct supply and growth stimulation
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Short-chain fatty acid-producing gut bacterium (null).